Immunogenicity and Safety of Homologous and Heterologous Booster Vaccination of ChAdOx1 nCoV-19 (COVISHIELD
TM) and BBV152 (COVAXIN®) in Previous Recipients of COVISHIELD
TM or COVAXIN®: A Phase 4, Participant and Observer Blinded, Randomised Study

doi:10.2139/ssrn.4143699

Immunogenicity and Safety of Homologous and Heterologous Booster Vaccination of ChAdOx1 nCoV-19 (COVISHIELD TM) and BBV152 (COVAXIN®) in Previous Recipients of COVISHIELD TM or COVAXIN®: A Phase 4, Participant and Observer Blinded, Randomised Study

2022 · doi:10.2139/ssrn.4143699

preprint OA: closed

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher →

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc: last seen: 2026-05-19T01:45:01.086888+00:00